glp 1 agonist weight loss mechanism GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes The GLP-1 Agonists and Obesity:

Key mechanisms of action include: Appetite suppression through central nervous system pathways that regulate hunger and satiety Delayed gastric emptying , which prolongs the sensation of fullness after eating Improved glucose metabolism and insulin sensitivity, which may benefit individuals with obesity-related metabolic complications GIP receptor antagonism , which may influence fat metabolism and energy storage The once-monthly dosing schedule is achieved through the extended half-life of the antibodypeptide construct, which may improve convenience and adherence compared with current weekly injectable obesity treatments

It is now licensed for use in T2D and for weight management

Capehorn, G

Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy

Gourdy P, Darmon P, Dievart F, et al

Thus far, alternative methodologies, such as artificial intelligence-based social network analyses, have yielded only qualitative insights.173 Few studies have specifically examined the relationship between GLP-1RAs and depression